Ara
Toplam kayıt 22, listelenen: 11-20
Is high thromboembolic risk not really associated with low time in therapeutic range in patients with prosthetic heart valves?
(Elsevier Ireland Ltd, 2019)
Dear Editor,
We have recently read with great interest the article reported by Poli et al. which was published in the last issue of International Journal of Cardiology [1]. We appreciate the authors for valuable contribution ...
Relationship between heparanase levels and prosthetic valve thrombosis: clinical implications
(Oxford Univ Press, 2017)
[Abstract Not Available]
Pregnancy in patients with prosthetic heart valve: ongoing challenges
(SAGE Publications Ltd, 2019)
[No abstract available]
Comparison of Different Anticoagulation Regimens Regarding Maternal and Fetal Outcomes in Pregnant Patients With Mechanical Prosthetic Heart Valves (from the Multicenter ANATOLIA-PREG Registry)
(Excerpta Medica Inc-Elsevier Science Inc, 2020)
Mechanical prosthetic heart valves (MPHVs) are highly thrombogenic, and a pregnancyinduced procoagulant status increases the risk of MPHV thrombosis. Despite numerous case reports, 2 major registries and meta-analyses/systematic ...
Diagnosis, treatment & management of prosthetic valve thrombosis: the key considerations
(Taylor & Francis Ltd, 2020)
Introduction: Prosthetic heart valve thrombosis is a life-threatening complication after valve replacement surgery. Although subtherapeutic anticoagulation is the main cause, there are many other conventional and esoteric ...
Is fibrinolytic therapy really safe in the treatment of prosthetic valve thrombosis in patients with high INR?
(Wiley, 2021)
To the Editor,
We have recently read with great interest the article by Farzaneh et al.1 entitled “Safety of thrombolytic therapy in patients with prosthetic heart valve thrombosis who have high international normalized ...
Low Dose and Slow/Ultra-Slow Infusion Thrombolytic Therapy Regimens are Effective and Safe in Patients With Prosthetic Valve Thrombosis
(Elsevier Science Inc, 2020)
To the Editor,We have recently read with great interest the article by Milneet al. entitled‘Management and outcomes of prosthetic valvethrombosis. An Australian case series from the NorthernTerritory’[1].
The relationship between incomplete surgical obliteration of the left atrial appendage and thromboembolic events after mitral valve surgery (from the ISOLATE Registry)
(Springer, 2021)
Left atrial appendage (LAA) is a common site of thrombus formation especially in patients with atrial fibrillation (AF). Complete surgical LAA closure (cSLC) is the surgical aim, however incomplete surgical LAA closure ...
Clinical safety and efficacy of thrombolytic therapy with low-dose prolonged infusion of tissue type plasminogen activator in patients with intermediate-high risk pulmonary embolism
(Lippincott Williams & Wilkins, 2020)
The patients with intermediate-high risk pulmonary embolism who have acute right ventricular (RV) dysfunction and myocardial injury without overt hemodynamic compromise may be candidates for thrombolytic therapy. Alternative ...
The value of brain natriuretic peptide in the prosthetic valve thrombosis
(Lippincott Williams & Wilkins, 2020)
We aimed to investigate how prosthetic valve thrombosis (PVT) affects brain natriuretic peptide (BNP) levels and how BNP changes following thrombolytic therapy. The study included 70 consecutive patients with left-sided ...